Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study

Related content

• Research output

• A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin

  Research output: Contribution to journal › Article › peer-review